Grants and Contributions:
Title:
Development and Validation of New Analytical Tools for Managing Complex Drug Trial Data
Agreement Number:
890526
Agreement Value:
$200,225.00
Agreement Date:
Jul 26, 2017 - Mar 31, 2019
Description:
The project will develop, refine, and validate two new analytical tools that can be used to expand the Firm's analytical service offerings.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Guy, Nova Scotia, CA B3J 2E3
Reference Number:
172-2018-2019-Q3-890526
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
863915765
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -89 days. The total amendment value is -16,184 dollars.
Amendment Date
Apr 8, 2019
Recipient's Legal Name:
DGI Clinical Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: